We’re excited to share our new peer-reviewed publication in Crohn’s & Colitis 360 journal, from our latest clinical trial at Cedars-Sinai. We used Dieta Health's AI to monitor stool characteristics in hospitalized severe ulcerative colitis patients and found statistically significant correlations between the stool characteristics and inflammation biomarkers (blood CRP). This paves the way for a new method of non-invasive IBD disease monitoring.
We are honored to co-author this research with Drs. Gil Melmed and Dermot McGovern, and the rest of the amazing IBD team at Cedars-Sinai! Read more below:
https://academic.oup.com/crohnscolitis360/advance-article/doi/10.1093/crocol/otae043/7741116
